Intractable Pneumothorax Treatment Market -t
Intractable
Pneumothorax Treatment Market - Industry Trends and Forecast to 2026 with key
players like Medtronic, Angiotech, BetaGlue, Teleflex Incorporated, Vygon SA,
Utah Medical Products, Inc, Smiths Group plc, ATMOS MedizinTechnik GmbH &
Co. KG, Sinapi Biomedical
Intractable
Pneumothorax Treatment Market By Types (Traumatic Pneumothorax and
Nontraumatic Pneumothorax), Drugs Class (Antibiotics, Benzodiazepines, Opiate
Anesthetics and Others), Diagnosis (Chest Radiography, CT Scan, Thoracic
Ultrasound and Others), Treatment (Medications, Supportive Care and Surgery),
Route of Administration (Oral, Inhalation and Parenteral), Distribution Channel
(Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), End-Users (Hospitals,
Homecare, Specialty Clinics and Others), Geography (North America, Europe,
Asia-Pacific, South America, Middle East and Africa) - Industry Trends and
Forecast to 2026
Market Analysis: Global Intractable Pneumothorax Treatment Market
Global intractable pneumothorax treatment market is growing at a
steady CAGR in the forecast period of 2021-2026. The report contains data of
the base year 2018 and historic year 2017. Increasing prevalence of respiratory
diseases such as COPD and asthma, increasing aging population across the world,
along with the rising healthcare expenditures are certain factors which can
augment the growth of this market.
Download
full sample report of Intractable Pneumothorax Treatment Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-intractable-pneumothorax-treatment-market
Market Definition: Global Intractable Pneumothorax Treatment Market
Intractable pneumothorax is a condition of collapsed lung. This
condition occurs when air leaks out in-between the spaces of lung and chest
wall. This air puts pressure on the lungs from outside and makes it collapse,
this can results in a complete lung collapse or a collapse of only a portion of
the lung. Pneumothorax can be caused by chest injuries which penetrates the
lungs, certain medical procedures, or from any lung disease. Symptoms include
sudden chest pain and shortness of breath.
Market Drivers
·
Increasing prevalence of
respiratory diseases such as COPD and asthma is driving the market growth
·
Availability of
effective treatment for the pneumothorax across different regions is boosting
the market growth
·
Increasing awareness
about the various respiratory diseases is expected to drive the market growth
·
Rising healthcare
expenditures can also act as a driver for the growth of this market
Market Restraints
·
Delayed diagnosis and
low rate of diagnosis of pneumothorax is hampering the market growth
·
Lack of awareness about
the pneumothorax in underdeveloped countries as well as developing countries is
also hindering the growth of this market
·
Limited availability of
medicinal treatment options can act as a major restricting factor in this
market growth
Segmentation: Global Intractable Pneumothorax Treatment Market
By Types
·
Traumatic Pneumothorax
·
Nontraumatic
Pneumothorax
By Drugs Class
·
Antibiotics
·
Benzodiazepines
·
Opiate Anesthetics
·
Others
By Diagnosis
·
Chest Radiography
·
CT Scan
·
Thoracic Ultrasound
·
Others
By Treatment
·
Medications
·
Supportive Care
·
Surgery
By Route of Administration
·
Oral
·
Inhalation
·
Parenteral
By Distribution Channel
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Pharmacy
By End-Users
·
Hospitals
·
Homecare
·
Specialty Clinics
By Geography
·
North America
o U.S.
o Canada
o Mexico
·
Europe
o Germany
o Italy
o U.K.
o France
o Spain
o Netherlands
o Belgium
o Switzerland
o Turkey
o Russia
o Rest of Europe
·
Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Singapore
o Malaysia
o Thailand
o Indonesia
o Philippines
o Rest of Asia Pacific
·
South America
o Brazil
o Rest of South America
·
Middle East & Africa
o South Africa
o Rest of Middle East & Africa
Key Developments in the Market
·
In August 2019,
Nobelpharma Co., Ltd is developing Unitalc for the treatment of patients with
intractable pneumothorax, currently ongoing in phase ll clinical trial. If
approved this drug will provide the potential treatment for the patients with
pneumothorax
·
In May 2019, Zebra
Medical Vision, Inc received the 510(k) U.S FDA approval for HealthPNX - an AI
alert for pneumothorax, based on chest X-rays. Approval of this device will
help in the early diagnosis of pneumothorax further assisting in improving the
patient care
Competitive Analysis:
Global
intractable pneumothorax treatment market is highly fragmented and the
major players have used various strategies such as new product launches, expansions,
agreements, joint ventures, partnerships, acquisitions, and others to increase
their footprints in this market. The report includes market shares of
intractable pneumothorax treatment drug market for Global, Europe, North
America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
The key market players in the global intractable pneumothorax
treatment market are Abbott, , Medtronic, Angiotech, BetaGlue, Teleflex
Incorporated, Vygon SA, Utah Medical Products, Inc, Smiths Group plc, ATMOS
MedizinTechnik GmbH & Co. KG, Sinapi Biomedical, , Nobelpharma Co., Ltd,
Zebra Medical Vision, Inc among others.
Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-intractable-pneumothorax-treatment-market
Reasons
for Buying this Report
This report provides pin-point analysis for changing
competitive dynamics
It provides a forward looking perspective on different
factors driving or restraining market growth
It provides a six-year forecast assessed on the basis
of how the market is predicted to grow
It helps in understanding the key product segments and
their future
It provides pin point analysis of changing competition
dynamics and keeps you ahead of competitors
It helps in making informed business decisions by
having complete insights of market and by making in-depth analysis of market
segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-intractable-pneumothorax-treatment-market
About
Us:
Data
Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting
firm with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient
information for your business to thrive in the market
Contact:
Tel:
+1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse
Related Reports @